AF recurrence by the 24-month follow-up were observed in 276 of 703 patients in the SGLT2i group and 599 of 1095 patients in the non-SGLT2i group, reflecting a reduction in AF recurrence in the SGLT2i group compared to non-SGLT2i group; however, this difference did not reach statistical significance (OR: 0.60, 95% CI: 0.28–1.28, p = 0.12, I 2 = 68%, Figure 4 e).
← all excerpts
Effects of Sodium Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrences After Catheter Ablation in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.
1
0.1200
0.1200